{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T23:08:02Z","timestamp":1788044882532,"version":"build-2784847793"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1002\/jps.22238","type":"journal-article","created":{"date-parts":[[2010,7,8]],"date-time":"2010-07-08T16:37:15Z","timestamp":1278607035000},"page":"133-149","source":"Crossref","is-referenced-by-count":8,"title":["Composite Fiber Structures with Antiproliferative Agents Exhibit Advantageous Drug Delivery and Cell Growth Inhibition In Vitro"],"prefix":"10.1016","volume":"100","author":[{"given":"Amir","family":"Kraitzer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoel","family":"Kloog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roni","family":"Haklai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meital","family":"Zilberman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1002\/jps.22238_bb0005","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0168-3659(00)00364-3","article-title":"Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers","volume":"71","author":"Feng","year":"2001","journal-title":"J Control Release"},{"key":"10.1002\/jps.22238_bb0010","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0378-5173(99)00087-3","article-title":"Localized paclitaxel delivery","volume":"183","author":"Dhanikula","year":"1999","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.22238_bb0015","series-title":"Handbook of coronary stents","first-page":"311","article-title":"The Boston Scientific antipropliferative, Paclitaxel eluting stent (TAXUS)","author":"Silber","year":"2001"},{"key":"10.1002\/jps.22238_bb0020","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1161\/hc3001.092037","article-title":"Pathological analysis of local delivery of paclitaxel via a polymer-coated stent","volume":"104","author":"Farb","year":"2001","journal-title":"Circulation"},{"key":"10.1002\/jps.22238_bb0025","doi-asserted-by":"crossref","first-page":"22263","DOI":"10.1074\/jbc.270.38.22263","article-title":"Selective inhibition of Ras-dependent cell growth by farnesylthiosalisylic acid","volume":"270","author":"Marom","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1002\/jps.22238_bb0030","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/01.ATV.0000112021.98971.f0","article-title":"Inhibition of intimal thickening in the rat carotid artery injury model by a nontoxic Ras inhibitor","volume":"24","author":"George","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1002\/jps.22238_bb0035","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.semcancer.2004.04.004","article-title":"Prenyl-binding domains: Potential targets for Ras inhibitors and anti-cancer drugs","volume":"14","author":"Kloog","year":"2004","journal-title":"Semin Cancer Biol"},{"key":"10.1002\/jps.22238_bb0040","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1161\/01.CIR.103.18.2289","article-title":"Paclitaxel stent coating inhibits neointimal hyperplasia at 4weeks in a porcine model of coronary restenosis","volume":"103","author":"Heldman","year":"2001","journal-title":"Circulation"},{"key":"10.1002\/jps.22238_bb0045","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jconrel.2007.04.022","article-title":"Release profiles in drug-eluting stents: Issues and uncertainties","volume":"120","author":"Venkatraman","year":"2007","journal-title":"J Control Release"},{"key":"10.1002\/jps.22238_bb0050","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1540-8183.2006.00198.x","article-title":"Polymers, drug release, and drug-eluting stents","volume":"19","author":"Commandeur","year":"2006","journal-title":"J Interv Cardiol"},{"key":"10.1002\/jps.22238_bb0055","doi-asserted-by":"crossref","first-page":"11709","DOI":"10.1158\/0008-5472.CAN-06-1878","article-title":"A Ras inhibitor tilts the balance between Rac and Rho and blocks phosphatidylinositol 3-kinase-dependent glioblastoma cell migration","volume":"66","author":"Goldberg","year":"2006","journal-title":"Cancer Res"},{"key":"10.1002\/jps.22238_bb0060","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/35052535","article-title":"Gliomagenesis: Genetic alterations and mouse models","volume":"2","author":"Holland","year":"2001","journal-title":"Nat Rev Genet"},{"key":"10.1002\/jps.22238_bb0065","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0168-3659(02)00212-2","article-title":"Paclitaxel-loaded PLGA nanoparticles: Preparation, physicochemical characterization and in vitro anti-tumoral activity","volume":"83","author":"Fonseca","year":"2002","journal-title":"J Control Release"},{"key":"10.1002\/jps.22238_bb0070","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0168-3659(02)00320-6","article-title":"A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS","volume":"86","author":"Mu","year":"2003","journal-title":"J Control Release"},{"key":"10.1002\/jps.22238_bb0075","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1023\/A:1016032207246","article-title":"Development of a polymeric surgical paste formulation for taxol","volume":"13","author":"Winternitz","year":"1996","journal-title":"Pharm Res"},{"key":"10.1002\/jps.22238_bb0080","first-page":"672","article-title":"Pharmacokinetics of interstitial delivery of carmustine, 4-hydroperoxycyclophosphamide, and paclitaxel from a biodegradable polymer implant in the monkey brain","volume":"58","author":"Fung","year":"1998","journal-title":"Cancer Res"},{"key":"10.1002\/jps.22238_bb0085","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3171\/jns.1991.74.3.0441","article-title":"Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas","volume":"74","author":"Brem","year":"1991","journal-title":"J Neurosurg"},{"key":"10.1002\/jps.22238_bb0090","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1007\/s11095-006-9036-z","article-title":"Electrospun micro- and nanofibers for sustained delivery of paclitaxel to treat C6 glioma in vitro","volume":"23","author":"Xie","year":"2006","journal-title":"Pharm Res"},{"key":"10.1002\/jps.22238_bb0095","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1016\/j.biomaterials.2008.04.002","article-title":"Biodegradable microfiber implants delivering paclitaxel for post-surgical chemotherapy against malignant glioma","volume":"29","author":"Ranganath","year":"2008","journal-title":"Biomaterials"},{"key":"10.1002\/jps.22238_bb0100","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jconrel.2007.11.011","article-title":"Long-term in vitro study of paclitaxel-eluting bioresorbable core\/shell fiber structures","volume":"126","author":"Kraitzer","year":"2008","journal-title":"J Control Release"},{"key":"10.1002\/jps.22238_bb0105","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1021\/bi972032d","article-title":"Dislodgment and accelerated degradation of Ras","volume":"37","author":"Haklai","year":"1998","journal-title":"Biochemistry"},{"key":"10.1002\/jps.22238_bb0110","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1158\/1535-7163.MCT-06-0706","article-title":"Suppression of lung cancer tumor growth in a nude mouse model by the Ras inhibitor salirasib (farnesylthiosalicylic acid)","volume":"6","author":"Zundelevich","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"10.1002\/jps.22238_bb0115","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1074\/jbc.270.7.2901","article-title":"Quantitative analysis of the complex between p21ras and the Ras-binding domain of the human Raf-1 protein kinase","volume":"270","author":"Herrmann","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1002\/jps.22238_bb0120","doi-asserted-by":"crossref","first-page":"37169","DOI":"10.1074\/jbc.M205698200","article-title":"Galectin-1 augments Ras activation and diverts Ras signals to Raf-1 at the expense of phosphoinositide 3-kinase","volume":"277","author":"Elad-Sfadia","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1002\/jps.22238_bb0125","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0169-409X(01)00116-8","article-title":"Mathematical modeling of bioerodible polymeric drug delivery systems","volume":"48","author":"Siepman","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1002\/jps.22238_bb0130","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/jbm.a.30188","article-title":"Physical characterization of controlled release of paclitaxel from the TAXUS Express2 drug-eluting stent","volume":"71","author":"Ranade","year":"2004","journal-title":"J Biomed Mater Res A"},{"key":"10.1002\/jps.22238_bb0135","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/mabi.200600129","article-title":"Biodegradable injectable in situ depot-forming drug delivery systems","volume":"6","author":"Chitkara","year":"2006","journal-title":"Macromol Biosci"},{"key":"10.1002\/jps.22238_bb0140","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/jbm.a.20101","article-title":"Poly(sebacic acid-co-ricinoleic acid) biodegradable carrier for paclitaxel: In vitro release and in vivo toxicity","volume":"69","author":"Shikanov","year":"2004","journal-title":"J Biomed Mater Res A"},{"key":"10.1002\/jps.22238_bb0145","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1158\/0008-5472.999.65.3","article-title":"Ras inhibition in glioblastoma down-regulates hypoxia-inducible factor-1alpha, causing glycolysis shutdown and cell death","volume":"65","author":"Blum","year":"2005","journal-title":"Cancer Res"},{"key":"10.1002\/jps.22238_bb0150","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1158\/1535-7163.MCT-06-0193","article-title":"Suppression of survivin expression in glioblastoma cells by the Ras inhibitor farnesylthiosalicylic acid promotes caspase-dependent apoptosis","volume":"5","author":"Blum","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"10.1002\/jps.22238_bb0155","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0076-6879(07)00432-6","article-title":"The Ras inhibitor farnesylthiosalicylic acid (Salirasib) disrupts the spatiotemporal localization of active Ras: A potential treatment for cancer","volume":"439","author":"Rotblat","year":"2008","journal-title":"Methods Enzymol"},{"key":"10.1002\/jps.22238_bb0160","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1021\/jm00008a004","article-title":"Farnesyl derivatives of rigid carboxylic acids-inhibitors of ras-dependent cell growth","volume":"38","author":"Marciano","year":"1995","journal-title":"J Med Chem"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915323273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915323273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T00:22:54Z","timestamp":1685665374000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354915323273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0022354915323273"],"URL":"https:\/\/doi.org\/10.1002\/jps.22238","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}